CIK 0001280776 · Non-accelerated filer<br>Smaller reporting company
IMMUNIC, INC.
Sign in to watch- Ticker
- IMUX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562358443
- Phone
- (332) 255-9818
- Business address
- 1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK, United States, 10036
- Former names
- VITAL THERAPIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-17 | Whaley Glenn Chief Financial Officer | Grant or award · Stock Option | +295,400 | 295,400 | ||
| 2023-06-28 | HOWSON TAMAR D Director | Grant or award · Stock Option | +16,000 | 16,000 | ||
| 2023-06-28 | PHILLIPS BARCLAY A Director | Grant or award · Stock Option | +16,000 | 16,000 | ||
| 2023-06-28 | Rudick Richard Alan Director | Grant or award · Stock Option | +16,000 | 16,000 | ||
| 2023-06-28 | Neermann Joerg Director | Grant or award · Stock Option | +16,000 | 16,000 | ||
| 2023-06-28 | Toernsen Monika Maria Director | Grant or award · Stock Option | +16,000 | 16,000 | ||
| 2023-05-15 | Whaley Glenn Chief Financial Officer | Purchase | +5,000 | $1.75 | $9K | 25,510 |
| 2023-04-26 | Rudick Richard Alan Director | Grant or award · Stock Option | +32,000 | 32,000 | ||
| 2023-01-02 | Muehler Andreas Chief Medical Officer | Grant or award · Stock Option | +132,000 | 132,000 | ||
| 2023-01-02 | Nash Duane Executive Chairman | Grant or award · Stock Option | +132,000 | 132,000 | ||
| 2023-01-02 | Whaley Glenn Chief Financial Officer | Grant or award · Stock Option | +110,000 | 110,000 | ||
| 2023-01-02 | Vitt Daniel Chief Executive Officer | Grant or award · Stock Option | +300,000 | 300,000 | ||
| 2022-12-14 | Neermann Joerg Director | Purchase | +47,000 | $1.26 | $59K | 100,000 |
| 2022-12-13 | Neermann Joerg Director | Purchase | +35,000 | $1.25 | $44K | 53,000 |
| 2022-11-23 | Neermann Joerg Director | Purchase | +18,000 | $1.39 | $25K | 18,000 |
| 2022-11-22 | Vitt Daniel President and CEO | Purchase | +8,000 | $1.35 | $11K | 376,877 |
| 2022-11-07 | Whaley Glenn Chief Financial Officer | Purchase | +5,000 | $1.50 | $7K | 20,510 |
| 2022-07-08 | Toernsen Monika Maria Director | Grant or award · Stock Option | +30,000 | 30,000 | ||
| 2022-06-15 | Nash Duane Executive Chairman | Grant or award · Stock Option | +10,000 | 10,000 | ||
| 2022-06-15 | Muehler Andreas Chief Medical Officer | Grant or award · Stock Option | +10,000 | 10,000 |
Page 8 of 9 · 170 trades